Skip to main content
Download PDF

The use of Apixaban for the treatment of an LV thrombus

Echo Research & Practice volume 5, pages K63–K66 (2018)Cite this article

Summary

A 42-year-old male was admitted with shortness of breath secondary to suspected heart failure and chest infection. An echocardiogram revealed a dilated and impaired left ventricle; ejection fraction 29%, with a large, mobile thrombus within the left ventricular apex. Due to the presence of liver dysfunction, vitamin K antagonists were deemed inappropriate; thus, the decision was taken to use the novel anticoagulation agent Apixaban. After 6 days of receiving Apixaban, a cardiac magnetic resonance scan was preformed, which showed complete resolution of the LV apical thrombus.

References

  1. Stokman PJ, Nandra CS & Asinger RW. Left ventricular thrombus. Current Treatment Options in Cardiovascular Medicine 2001 3 515–521. (https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s11936-001-0025-6)

    Article  Google Scholar 

  2. Esposito R, Raia R, De Palma D, Santoro C & Galderisi M. The evolving role and use of echocardiography in the evaluation of cardiac source of embolism. Journal of Cardiovascular Echography 2017 27 33–44. (https://doiorg.publicaciones.saludcastillayleon.es/10.4103/jcecho.jcecho_1_17)

    Article  Google Scholar 

  3. Steg G, James SK, Atra D, Badano LP, Lundqvist CB, Borger MA, Di Mario C, Dickstein K, Fernandez-Aviles GDF, Gershlick AH, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. European Heart Journal 2012 33 2569–2619. (https://doiorg.publicaciones.saludcastillayleon.es/10.1093/eurheartj/ehs215)

    Article  CAS  Google Scholar 

  4. Miller CS, Grandi SM, Shimony A, Filion KB & Eisenberg MJ. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. American Journal of Cardiology 2012 110 453–460. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.amjcard.2012.03.049)

    Article  CAS  Google Scholar 

  5. Mekaj YH, Mekaj AY, Duci SB & Miftari EI. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events. Therapeutics and Clinical Risk Management 2015 11 967–977. (https://doiorg.publicaciones.saludcastillayleon.es/10.2147/TCRM.S84210)

    Article  Google Scholar 

  6. National Institute for Health and Care Excellence. Pulmonary embolism. Scenario: Managing confirmed pulmonary embolism. London, UK: NICE, 2015. (available at: https://cks.nice.org.uk/pulmonary-embolism#!scenario:1)

    Google Scholar 

  7. Sun H, Zhao Q, Wang Y, Lakin R, Feng H, Fan Z, Luo H, Gao D, Liu L, He Y, et al. Daily 10 mg rivaroxaban as a therapy for ventricular thrombus related to left ventricular non-compaction cardiomyopathy. A case report. Medicine 2018 97 9670. (https://doiorg.publicaciones.saludcastillayleon.es/10.1097/MD.0000000000009670)

    Article  Google Scholar 

  8. Kaya A, Hayıroğlu MI, Keskin M, Tekkeşin AI & Alper AT. Resolution of left ventricular thrombus with apixaban in a patient with hypertrophic cardiomyopathy. Turk Kardiyoloji Dernegi Arsivi 2016 44 335–337. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.ijcac.2015.12.004)

    PubMed  Google Scholar 

  9. Las Casas AA Jr, Las Casas AA, Marco Borges MAF, Melo-Souza SE. Rivaroxaban for treatment of intraventricular thrombus in Chagas disease. Journal of Cardiology Cases 2016 12 75–77. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jccase.2015.10.010)

    Article  Google Scholar 

  10. Bahmaid R, Ammar S, Al-Subaie S, Soofi M, Mhish H & Yahia M. Efficacy of Target Specific Oral Anticoagulants on the resolution of left ventricular thrombus. Surgical Case Report Review 2018. (https://doiorg.publicaciones.saludcastillayleon.es/10.15761/SCRR.1000107)

    Google Scholar 

Download references

Funding

This work did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Author information

Authors and Affiliations

  1. Heart & Lung Centre, Royal Stoke, University Hospitals of the North Midlands, Stoke-On-Trent, UK

    Sadie Bennett BSc MSc & Duwarakan Satchithananda FRCP and Gareth Law BSc

Authors
  1. Sadie Bennett BSc MSc
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Duwarakan Satchithananda FRCP and Gareth Law BSc
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Sadie Bennett BSc MSc.

Rights and permissions

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.(http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bennett, S., Satchithananda, D. The use of Apixaban for the treatment of an LV thrombus. Echo Res Pract 5, K63–K66 (2018). https://doiorg.publicaciones.saludcastillayleon.es/10.1530/ERP-18-0036

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1530/ERP-18-0036

Key Words

Echo Research & Practice

ISSN: 2055-0464

Contact us